CLINICAL_TRIALS
withdrawal
· 2024-08-07
Clinical Trial Update: Antiorbital Calcium in Chronic Conditions [NA]
Summary
The clinical trial evaluating Antiorbital Calcium for atrial fibrillation has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National University of Natural Medicine | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN